Skip to main content
Vision Impairment in Stroke: Intervention Or Not Coordinated by the Clinical Trials Research Centre, University of Liverpool
A clinical trial in stroke vision rehabilitation

VISION: Vision Impairment in Stroke, Intervention Or Not

VISION is a clinical trial that compares the effectiveness of prism glasses, visual search and standard care (information only) in patients who have a homonymous hemianopia following a stroke.

The VISION trial emblem, an eye with the word VISION in the centre

Vision Impairment in Stroke: Intervention Or Not

Recruitment status See the current list of recruiting centres
About the trial

Three approaches, compared in one randomised trial

Participants are randomly assigned to one of three treatment methods. The trial then measures visual field and quality of life to find out which approach works best.

1

Prism glasses

An optical plastic membrane that displaces the images viewed through the prism, aiming to bring the lost side of the visual field back into view.

2

Visual search training

Training that encourages a person to look systematically to the right and to the left, so the blind side of the visual field is scanned more often.

3

Information only

The control group receives information about visual field loss and standard care, with no additional rehabilitation therapy.

Why VISION matters

Visual field loss after stroke is common and under served

A stroke can affect people in many different ways and leave a range of persisting side effects. Visual field loss is one of the most commonly reported, and it can seriously affect functional ability and quality of life. People who lose part of their visual field after a stroke can be more prone to falls, and their participation in rehabilitation may be hampered. Despite this, service provision for stroke patients with suspected visual field loss is inconsistent, and there are no clear guidelines on how these patients should be visually rehabilitated.

VISION was undertaken to explore the visual rehabilitation of patients who lose either the left or the right half of the visual field in both eyes, a condition known as homonymous hemianopia, following a stroke.

3 Treatment arms compared
3 Assessment points at 6, 12 and 26 weeks
1 Condition studied: homonymous hemianopia
How the trial works

From randomisation to follow up assessment

What is measured

Visual field assessments take place at 6, 12 and 26 weeks after treatment starts. A quality of life questionnaire is completed by participants at the same points.

By combining these measures, the trial hopes to show whether rehabilitation methods improve functional outcome more than information alone.

Read the full trial summary

What the trial hopes to answer

The trial also hopes to establish whether prism glasses or visual search training are the most effective at improving functional outcome.

Read the glossary of terms to understand the language used in the trial, from homonymous hemianopia to visual scanning.

Latest news

Website released

13 May 2011

The VISION trial Website was released to share the trial background, the collaborative team and the recruiting centres with patients, clinicians and researchers.

See the news and updates archive